|
1
|
Morrissey C, Martinez A, Zatyka M, et al:
Epigenetic inactivation of the RASSF1A 3p21.3 tumor suppressor gene
in both clear cell and papillary renal cell carcinoma. Cancer Res.
61:7277–7281. 2001.PubMed/NCBI
|
|
2
|
Kawai Y, Sakano S, Suehiro Y, et al:
Methylation level of the RASSF1A promoter is an independent
prognostic factor for clear-cell renal cell carcinoma. Ann Oncol.
21:1612–1617. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Baylin SB and Jones PA: A decade of
exploring the cancer epigenome-biological and translational
implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Christensen BC, Houseman EA, Marsit CJ, et
al: Aging and environmental exposures alter tissue-specific DNA
methylation dependent upon CpG island context. PLoS Genet.
5:e10006022009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gharizadeh B, Nordström T, Ahmadian A, et
al: Long-read pyrosequencing using pure
2′-deoxyadenosine-5′-O'-(1-thiotriphosphate) Sp-isomer. Anal
Biochem. 301:82–90. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Minardi D, Lucarini G, Filosa A, et al:
Prognostic role of global DNA-methylation and histone acetylation
in pT1a clear cell renal carcinoma in partial nephrectomy
specimens. J Cell Mol Med. 13:2115–2121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Houseman EA, Accomando WP, Koestler DC, et
al: DNA methylation arrays as surrogate measures of cell mixture
distribution. BMC Bioinformatics. 13:862012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bibikova M, Le J, Barnes B, et al:
Genome-wide DNA methylation profiling using Infinium® assay.
Epigenomics. 1:177–200. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dessau RB and Pipper CB: ‘R’-project for
statistical computing. Ugeskr Laeger. 170:328–330. 2008.(In
Danish). PubMed/NCBI
|
|
10
|
Zhao Y, Guo S, Sun J, et al: Methylcap-seq
reveals novel DNA methylation markers for the diagnosis and
recurrence prediction of bladder cancer in a Chinese population.
PLoS One. 7:e351752012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
He Y, Cui Y, Wang W, et al:
Hypomethylation of the hsa-miR-191 locus causes high expression of
hsa-mir-191 and promotes the epithelial-to-mesenchymal transition
in hepatocellular carcinoma. Neoplasia. 13:841–853. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yu J, Zhu T, Wang Z, et al: A novel set of
DNA methylation markers in urine sediments for sensitive/specific
detection of bladder cancer. Clin Cancer Res. 13:7296–7304. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen YA, Choufani S, Ferreira JC,
Grafodatskaya D, Butcher DT and Weksberg R: Sequence overlap
between autosomal and sex-linked probes on the Illumina
HumanMethylation27 microarray. Genomics. 97:214–222. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Braun R, Finney R, Yan C, et al: Discovery
analysis of TCGA data reveals association between germline genotype
and survival in ovarian cancer patients. PLoS One. 8:e550372013.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin J, Cardozo T, Lovering RC, Elledge SJ,
Pagano M and Harper JW: Systematic analysis and nomenclature of
mammalian F-box proteins. Genes Dev. 18:2573–2580. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhou ZY, Tu KS, Zhang J, et al: Expression
of Fbxw7 and its correlation with cell proliferation in human
hepatocellular carcinoma. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi.
28:1303–1306. 2012.(In Chinese). PubMed/NCBI
|
|
17
|
Clarke CJ, Guthrie JM and Hannun YA:
Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor
necrosis factor-alpha involves protein kinase C-delta in lung
epithelial cells. Mol Pharmacol. 74:1022–1032. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Demircan B, Dyer LM, Gerace M, Lobenhofer
EK, Robertson KD and Brown KD: Comparative epigenomics of human and
mouse mammary tumors. Genes Chromosomes Cancer. 48:83–97. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Y, Takahashi M, Byun HM, et al:
Boswellic acid induces epigenetic alterations by modulating DNA
methylation in colorectal cancer cells. Cancer Biol Ther.
13:542–552. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chaturvedi P and Parnaik VK: Lamin A rod
domain mutants target heterochromatin protein 1alpha and beta for
proteasomal degradation by activation of F-box protein, FBXW10.
PLoS One. 5:e106202010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tang Y, Liu C, Wang X, Liu D, Ingvarsson S
and Chen H: Demethylation of the region around exon 2 of MLH1 gene
in gastrointestinal cancer. Anticancer Res. 32:4861–4864.
2012.PubMed/NCBI
|
|
22
|
Godler DE, Slater HR, Bui QM, et al: FMR1
intron 1 methylation predicts FMRP expression in blood of female
carriers of expanded FMR1 alleles. J Mol Diagn. 13:528–536. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Smaldone MC and Uzzo RG: Active
surveillance: a potential strategy for select patients with small
renal masses. Future Oncol. 7:1133–1147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lane BR, Tobert CM and Riedinger CB:
Growth kinetics and active surveillance for small renal masses.
Curr Opin Urol. 22:353–359. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mason RJ, Abdolell M, Trottier G, et al:
Growth kinetics of renal masses: analysis of a prospective cohort
of patients undergoing active surveillance. Eur Urol. 59:863–867.
2011. View Article : Google Scholar : PubMed/NCBI
|
